Monte Rosa Therapeutics Stock (NASDAQ: GLUE) stock price, news, charts, stock research, profile.
You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.
Other companies in Monte Rosa Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
Monte Rosa Therapeutics has a consensus price target of $16.00.
The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $5.51 last updated September 25, 2024 at 2:08 PM EDT.
There are no upcoming dividends for Monte Rosa Therapeutics.
Monte Rosa Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Monte Rosa Therapeutics.
Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.